175 related articles for article (PubMed ID: 2939233)
21. Effects of repeated administration of the monoamine oxidase inhibitor phenelzine on the discriminability of d-lysergic acid diethylamide (LSD) and 1-(m-trifluoromethylphenyl) piperazine (TFMPP).
Cunningham KA; Carroll BA; Appel JB
Psychopharmacology (Berl); 1986; 89(1):134-5. PubMed ID: 3090587
[TBL] [Abstract][Full Text] [Related]
22. The quipazine- and TFMPP-increased conditioned avoidance response in rats: role of 5HT1C/5-HT2 receptors.
Alhaider AA; Ageel AM; Ginawi OT
Neuropharmacology; 1993 Dec; 32(12):1427-32. PubMed ID: 8152532
[TBL] [Abstract][Full Text] [Related]
23. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats.
Sánchez H; Velázquez-Martínez DN
J Psychopharmacol; 2001 Mar; 15(1):29-36. PubMed ID: 11277605
[TBL] [Abstract][Full Text] [Related]
24. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists.
Prosser RA; Dean RR; Edgar DM; Heller HC; Miller JD
J Biol Rhythms; 1993; 8(1):1-16. PubMed ID: 8490207
[TBL] [Abstract][Full Text] [Related]
25. Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl)piperazine.
Herndon JL; Pierson ME; Glennon RA
Pharmacol Biochem Behav; 1992 Nov; 43(3):739-48. PubMed ID: 1333084
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
27. Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.
Friedman RL; Barrett RJ; Sanders-Bush E
J Pharmacol Exp Ther; 1984 Mar; 228(3):628-35. PubMed ID: 6707913
[TBL] [Abstract][Full Text] [Related]
28. Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors.
Callahan PM; Cunningham KA
J Pharmacol Exp Ther; 1995 Sep; 274(3):1414-24. PubMed ID: 7562516
[TBL] [Abstract][Full Text] [Related]
29. A pharmacological analysis of the rat spinal cord serotonin (5-HT) autoreceptor.
Brown L; Amedro J; Williams G; Smith D
Eur J Pharmacol; 1988 Jan; 145(2):163-71. PubMed ID: 2965026
[TBL] [Abstract][Full Text] [Related]
30. Induction of purposeless chewing behaviour in rats by 5-HT agonist drugs.
Stewart BR; Jenner P; Marsden CD
Eur J Pharmacol; 1989 Mar; 162(1):101-7. PubMed ID: 2524394
[TBL] [Abstract][Full Text] [Related]
31. Serotonin-mediated inhibitory postsynaptic potential in guinea-pig prepositus hypoglossi and feedback inhibition by serotonin.
Bobker DH; Williams JT
J Physiol; 1990 Mar; 422():447-62. PubMed ID: 2141079
[TBL] [Abstract][Full Text] [Related]
32. 5-HT1A and 5-HT1B agonists play a differential role on the respiratory frequency in rats.
Edwards E; Whitaker-Azmitia PM; Harkins K
Neuropsychopharmacology; 1990 Apr; 3(2):129-36. PubMed ID: 2138459
[TBL] [Abstract][Full Text] [Related]
33. The effects of intraventricular administration of eltoprazine, 1-(3-trifluoromethylphenyl)piperazine hydrochloride and 8-hydroxy-2-(di-n-propylamino)tetralin on resident intruder aggression in the rat.
Mos J; Olivier B; Poth M; van Aken H
Eur J Pharmacol; 1992 Mar; 212(2-3):295-8. PubMed ID: 1534769
[TBL] [Abstract][Full Text] [Related]
34. Do functional relationships exist between 5-HT1A and 5-HT2 receptors?
Darmani NA; Martin BR; Pandey U; Glennon RA
Pharmacol Biochem Behav; 1990 Aug; 36(4):901-6. PubMed ID: 2145593
[TBL] [Abstract][Full Text] [Related]
35. A comparison of the effects of the 5-HT1 agonists TFMPP and RU 24969 on feeding following peripheral or medial hypothalamic injection.
Fletcher PJ; Ming ZH; Zack MH; Coscina DV
Brain Res; 1992 May; 580(1-2):265-72. PubMed ID: 1387034
[TBL] [Abstract][Full Text] [Related]
36. Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
Glennon RA
Life Sci; 1986 Sep; 39(9):825-30. PubMed ID: 2943960
[TBL] [Abstract][Full Text] [Related]
37. The role of 5HT1A receptors in the modulation of the acoustic startle reflex in rats.
Nanry KP; Tilson HA
Psychopharmacology (Berl); 1989; 97(4):507-13. PubMed ID: 2524858
[TBL] [Abstract][Full Text] [Related]
38. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.
Yamamoto T; Walker EA; Woods JH
J Pharmacol Exp Ther; 1991 Sep; 258(3):999-1007. PubMed ID: 1890629
[TBL] [Abstract][Full Text] [Related]
39. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
40. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Dumuis A; Sebben M; Bockaert J
Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
